1 Cardiovascular Medicine Division, University of Pennsylvania, Philadelphia, PA, USA.
2 Cardiology, Massachusetts General Hospital, Boston, MA, USA.
Vasc Med. 2018 Feb;23(1):60-64. doi: 10.1177/1358863X17739697. Epub 2017 Nov 10.
Mortality associated with high-risk pulmonary embolism (PE) remains high. Extra-corporeal membrane oxygenation (ECMO) allows for acute hemodynamic stabilization and potentially for administration of other disease process altering therapies. We sought to compare two eras: pre-ECMO and post-ECMO in relation to high-risk PE treatment and mortality. A single-center retrospective chart review was conducted of high-risk PE patients. High-risk PE was defined as acute PE and cardiac arrest or shock. A total of 60 patients were identified, 31 in the pre-ECMO era and 29 in the post-ECMO era. Mean age was 56.1±21.1 years and 51.7% were women. More patients in the post-ECMO era were identified with computed tomography (82.8% vs 51.6%, p=0.011) and more patients in the post-ECMO era had right ventricular dysfunction on echocardiography (96.4% vs 78.3%, p=0.045). No other differences were noted in baseline characteristics or clinical, laboratory and imaging data between the two groups. In total, ECMO was used in 13 (44.8%) patients in the post-ECMO era. There was greater utilization of catheter-directed therapies in the post-ECMO era compared to the pre-ECMO era ( n = 7 (24.1%) vs n = 1 (3.2%), p=0.024). Thirty-day survival increased from 17.2% in patients who presented in the pre-ECMO era to 41.4% in the post-ECMO era ( p=0.043). While more work is necessary to better identify those PE patients who stand to benefit from mechanical circulatory support, our findings have important implications for the management of such patients.
高危肺栓塞(PE)相关死亡率仍然很高。体外膜氧合(ECMO)可实现急性血液动力学稳定,并有可能进行其他改变疾病进程的治疗。我们旨在比较 ECMO 前后两个时期高危 PE 治疗和死亡率的差异。对高危 PE 患者进行了单中心回顾性图表审查。高危 PE 定义为急性 PE 合并心脏骤停或休克。共确定了 60 例患者,其中 31 例为 ECMO 前时期,29 例为 ECMO 后时期。平均年龄为 56.1±21.1 岁,51.7%为女性。ECMO 后时期更多的患者接受了计算机断层扫描(82.8%比 51.6%,p=0.011),ECMO 后时期更多的患者出现右心室功能障碍(96.4%比 78.3%,p=0.045)。两组之间在基线特征或临床、实验室和影像学数据方面没有其他差异。在 ECMO 后时期,共有 13 例(44.8%)患者使用 ECMO。与 ECMO 前时期相比,ECMO 后时期更倾向于使用导管导向治疗( n = 7(24.1%)比 n = 1(3.2%),p=0.024)。30 天生存率从 ECMO 前时期的 17.2%上升至 ECMO 后时期的 41.4%( p=0.043)。虽然还需要进一步研究,以更好地确定那些从机械循环支持中获益的 PE 患者,但我们的研究结果对这类患者的治疗具有重要意义。